| Methods |
Double‐blinded, placebo‐controlled, randomised controlled trial |
| Participants |
Hospitalised infants younger than 24 months with clinically confirmed viral lower respiratory tract infection |
| Interventions |
Azithromycin 10 mg/kg/day, once daily for 3 days |
| Outcomes |
Respiratory rate, accessory muscle use, malaise severity, disease complications, use of alternative therapies, length of hospital stay, length of intensive care stay, deaths, need for NG feeding |
| Notes |
― |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
Adequate block randomisation |
| Allocation concealment (selection bias) |
Low risk |
|
| Blinding (performance bias and detection bias)
All outcomes |
Low risk |
Participants and doctors |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
No loss to follow‐up |
| Selective reporting (reporting bias) |
Low risk |
|
| Other bias |
Unclear risk |
Funding sources do not appear to be identified |
